OneAscent Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
OneAscent Wealth Management's GILD Position: Q2 2026 in Review
OneAscent Wealth Management increased its Gilead Sciences (GILD) stake by 5% in Q2 2026, buying an estimated $14.5K and bringing the position to 2,302 shares worth $291K. The position accounts for 0.09% of the portfolio, ranked #126.
OneAscent Wealth Management first reported a position in GILD in Q4 2020 and has held it in 17 quarters since. The position peaked at $686K in Q1 2021. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- OneAscent Wealth Management held 2,302 shares of Gilead Sciences worth $291K as of Q2 2026.
- OneAscent Wealth Management bought 110 Gilead Sciences shares in Q2 2026, an estimated $14.5K.
- Gilead Sciences made up 0.09% of OneAscent Wealth Management's portfolio in Q2 2026, its #126 holding.
- OneAscent Wealth Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 17 quarters since.
- OneAscent Wealth Management's Gilead Sciences position peaked at $686K in Q1 2021.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on OneAscent Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.